Companies: 10,795·Total market cap: $144.5T
Revance Therapeutics, Inc.

Revance Therapeutics, Inc.

RVNCNASDAQHealthcare
$3.65
+$0.00(+0.00%)
Market Cap$381023500
P/E Ratio
52W High$7.56
52W Low$2.3

Revance Therapeutics, Inc. (RVNC) Stock Splits

No forward or reverse splits on record since IPO — details below.

FMP · RVNC · as of Feb 6, 2025

Key split metrics

Revance Therapeutics, Inc. (RVNC) has been publicly traded since Feb 6, 2014 with no forward or reverse splits on record.

About stock split history

Revance Therapeutics, Inc. (RVNC) has never undergone a stock split since going public.

Frequently asked questions

Revance Therapeutics, Inc. (RVNC) has never split its stock since going public.

RVNC stock split historyhas RVNC ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.